Deracoxib
SIGMA/SML2014 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 169590-41-4
Empirical Formula (Hill Notation): C17H14F3N3O3S
Molecular Weight: 397.37
Linear Formula: C17H14F3N3O3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to brown |
| form | powder |
| InChI | 1S/C17H14F3N3O3S/c1-26-16 |
| InChI key | WAZQAZKAZLXFMK-UHFFFAOYSA |
| SMILES string | FC(F)c1n[n](c(c1)c3cc(c(c |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | room temp |
| Biochem/physiol Actions: | Deracoxib is an orally active cyclooxygenase-2 (COX-2) inhibitor with >48-fold selectivity over COX-1 (IC50 of 203-189 nM against COX-2-dependent PGE2 production vs. IC50 of 9.85-9.96 μM against COX-1-dependent TxB2 production in dog whole blood). Deracoxib is also reported to exhibit inhibitory activity against phosphodiesterase (Ki = 3.6 μM against human PDE4D3) as well as positive modulatory effiacy toward 2-APB-stimulated transient receptor potential vanilloid 3 channel (TRPV3) activity. |
| Biochem/physiol Actions: | Orally active COX-2 inhibitor with >48-fold selectivity over COX-1. Also inhibits PDE4D3 and enhances 2-APB-stimulated TRPV3 activity. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |

